Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies
about
Status of PI3K/Akt/mTOR pathway inhibitors in lymphomaPreclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor modelsOncogene withdrawal engages the immune system to induce sustained cancer regression.An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancerRigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer.Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
P2860
Q27026544-D76BE3C1-C677-4AB2-ADF8-BDE3285D3D41Q33578960-999C084A-C9EA-4214-970D-7BE2A2A9273FQ33987633-B64B6CA4-B66F-4193-BA29-6F85A90A3C66Q34361976-0DB88063-9B57-4B2D-8531-4972547DDC40Q37711623-BFF7CA87-B88E-4E4D-986A-5F71F1238C2AQ37733073-45F87F42-6474-45B7-BCF1-DE23C63E7ECDQ38128358-71C24B92-F8C0-4E2B-805F-742FE3650159Q38521775-9E54AED7-880A-483D-B861-96EB1336AD86Q47169310-693DFC03-A4C9-4B2E-BDB7-89C25D8788B7
P2860
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@ast
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@en
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@nl
type
label
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@ast
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@en
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@nl
prefLabel
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@ast
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@en
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@nl
P2093
P2860
P356
P1433
P1476
Phase I study of ON 01910.Na ( ...... refractory B-cell malignancies
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2013.79
P577
2013-03-14T00:00:00Z
P5875
P6179
1003035399